These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 851197)

  • 1. Inhibition of endo- and epicardial glycogenolysis by propranolol in ischemic hearts.
    Ichihara K; Abiko Y
    Am J Physiol; 1977 Apr; 232(4):H349-53. PubMed ID: 851197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference between endocardial and epicardial utilization of glycogen in the ischemic heart.
    Ichihara K; Abiko Y
    Am J Physiol; 1975 Dec; 229(6):1585-9. PubMed ID: 1082247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of pretreatment with carteolol on metabolic changes induced by coronary artery ligation in dog left ventricular wall (author's transl)].
    Saitoh Y; Ichihara K; Abiko Y
    Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):597-603. PubMed ID: 336485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of nitroglycerin, dipyridamole, and propranolol on glycogen metabolism during coronary artery ligation in dogs.
    Ichihara K; Abiko Y
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():531-5. PubMed ID: 829648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dipyridamole on the glycogen metabolism in the normal and ischemic canine myocardium.
    Ichihara K; Abiko Y
    Experientia; 1975 Oct; 31(10):1198-9. PubMed ID: 1204739
    [No Abstract]   [Full Text] [Related]  

  • 6. Temporal changes in endocardial energy metabolism following propranolol and the metabolic basis for protection against isoprenaline cardiotoxicity.
    Pieper GM; Clayton FC; Todd GL; Eliot RS
    Cardiovasc Res; 1979 Apr; 13(4):207-14. PubMed ID: 466661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of verapamil and nifedipine on ischemic myocardial metabolism in dogs.
    Ichihara K; Ichihara M; Abiko Y
    Arzneimittelforschung; 1979; 29(10):1539-44. PubMed ID: 583218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of niludipine on ischemic myocardial metabolism in the dog.
    Ichihara K; Ichihara M; Abiko Y
    Arzneimittelforschung; 1980; 30(5):785-91. PubMed ID: 7190421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neural factor involved in increase of the glycogen phosphorylase activity after coronary ligation in both ischemic and nonischemic areas of the dog heart.
    Sakai K; Abiko Y
    Circ Res; 1982 Dec; 51(6):733-42. PubMed ID: 6128082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of trimetazidine on utilization of myocardial glycogen during coronary ligation in dogs.
    Sakai K; Fukushi Y; Abiko Y
    Pharmacology; 1986; 32(2):72-9. PubMed ID: 3952133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmural gradients in ventricular tissue metabolites produced by stopping coronary blood flow in the dog.
    Dunn RB; Griggs DM
    Circ Res; 1975 Oct; 37(4):438-45. PubMed ID: 1182935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute changes of myocardial norepinephrine and glycogen phosphorylase in ischemic and non-ischemic areas after coronary ligation in dogs.
    Sakai K; Abiko Y
    Jpn Circ J; 1981 Nov; 45(11):1250-5. PubMed ID: 7300006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between myocardial metabolism and epicardial ST segment alterations during myocardial ischemia.
    Willerson JT; Templeton GH; Karlsson J
    Recent Adv Stud Cardiac Struct Metab; 1975; 5():335-40. PubMed ID: 1188166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmural gradients of left ventricular tissue metabolites after circumflex artery ligation in dogs.
    Allison TB; Ramey CA; Holsinger JW
    J Mol Cell Cardiol; 1977 Oct; 9(10):837-52. PubMed ID: 915954
    [No Abstract]   [Full Text] [Related]  

  • 15. Crossover plot study of glycolytic intermediates in the ischemic canine heart.
    Ichihara K; Abiko Y
    Jpn Heart J; 1982 Sep; 23(5):817-28. PubMed ID: 6217359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial cyclic nucleotide levels after coronary artery ligation.
    Lindenau KF; Krause EG; Bartel S; Kensicki C; Knauer S; Wollenberger A
    Z Exp Chir; 1981 Feb; 14(1):44-8. PubMed ID: 6263017
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of glycogenolysis inhibition in the etiology of arrhythmias in coronary disease].
    Sysoliatina NA; Sapozhkov AV
    Vopr Med Khim; 1982; 28(6):56-9. PubMed ID: 7157722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
    Hayase N; Chiba K; Ichihara K; Inagaki S; Abiko Y
    J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia.
    Tanabe T; Usui K; Kusuzaki S; Yoshitake M; Takigawa O; Iwamoto T; Handa S
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):824-30. PubMed ID: 9436824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the "border zone" in acute regional ischemia in the dog.
    Hearse JD; Opie LH; Katzeff IE; Lubbe WF; Van der Werff TJ; Peisach M; Boulle G
    Am J Cardiol; 1977 Nov; 40(5):716-26. PubMed ID: 920608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.